Author:
Kojima Masahiro,Wende Wu,Zhao Henry
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Yuan Y, Lee JJ, Hilsenbeck SG. Model-assisted designs for early-phase clinical trials: simplicity meets superiority. JCO Precision Oncol. 2019;3:1–12.
2. Yuan Y, Hess KR, Hilsenbeck SG, Gilbert MR. Bayesian optimal interval design: a simple and well-performing design for phase I oncology trials. Clin Cancer Res. 2016;22(17):4291–301.
3. U.S. Food & Drug Administration. Drug Development Tools: Fit-for-Purpose Initiative. https://www.fda.gov/drugs/development-approval-process-drugs/drug-development-tools-fit-purpose-initiative
4. Ananthakrishnan R, Lin R, He C, Chen Y, Li D, LaValley M. An overview of the BOIN design and its current extensions for novel early-phase oncology trials. Contemp Clin Trials Commun. 2022;28:100943.
5. Pharmaceuticals and Medical Devices Agency. 「第7回 データサイエンスラウンドテーブル会議」の開催について. https://www.pmda.go.jp/review-services/symposia/0104.html